The Art and Science of Managing the New Melanoma Landscape

1. Utilize the latest criteria and clinical evidence for treatment options for melanoma patients with clinically localized disease and interpret the components of the updated AJCC staging system for melanoma
2. Make evidence-based decisions about the use of adjuvant immune and targeted therapies in patients with surgically resected stage III disease

Physicians (MD’s/DO’s)

• Postmarked before December 16……..$375
• Postmarked after December 16……….$425

Fellows/Residents

• Postmarked before December 16.........$75       
• Postmarked after December 16..........$100

RNs/NPs/PAs/Pharmacists ·      

• Postmarked before December 16……..$200 ·      
• Postmarked after December 16…….….$250

Medical Students………………………………$35

AAEM members: 25% discount if they provide membership number Speakers: Complimentary

Exhibitors: $2,000

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

CloudCME® reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
CloudCME® is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

CloudCME® adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Michael Davies, MD, PhD
Professor and Chairman Chairman of the Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

Patrick Hwu, MD
Professor, Department of Melanoma Medical Oncology
MD Anderson Cancer Center

Faculty

Jennifer McQuade, MD
Assistant Professor and Physician Scientist in Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center

Faculty

NICHOLE E PLUGGE, APRN
HealthStream

Faculty

Nothing to disclose

Michael Postow, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center

Faculty

Karl Wilkens, MD
CloudCME

Faculty

Nothing to disclose

 Please click the "Exhibit at this Event" button below to begin.